76 related articles for article (PubMed ID: 3887536)
1. [A transdermal therapeutic estradiol system for physiological hormone substitution in the menopause].
Schenkel L
Schweiz Rundsch Med Prax; 1985 Mar; 74(11):277-82. PubMed ID: 3887536
[No Abstract] [Full Text] [Related]
2. [Ovarian stimulation in menopause. Placebo-controlled double-blind study of the effectiveness and tolerance of the splenic dialysate Solcosplen in climacteric complaints in the female].
Siedentopf HG
Fortschr Med; 1988 Mar; 106(8):161-4. PubMed ID: 3288544
[No Abstract] [Full Text] [Related]
3. [Comparison of transdermal and subcutaneous administration of estradiol in the treatment of climacteric symptoms].
van Leusden HA
Ned Tijdschr Geneeskd; 1987 Dec; 131(50):2301-4. PubMed ID: 3696269
[No Abstract] [Full Text] [Related]
4. [Transdermal estradiol substitution in the postmenopause, individual dosage adjustment and effectiveness in the treatment of climacteric symptoms].
Schenkel L; von Graffenried A
Schweiz Rundsch Med Prax; 1987 Mar; 76(14):358-61. PubMed ID: 3589291
[No Abstract] [Full Text] [Related]
5. [Climacteric syndrome : clinical experiences using promestriene].
Campana G; Di Grancesco
Ann Ostet Ginecol Med Perinat; 1976; 97(3):189-97. PubMed ID: 797296
[No Abstract] [Full Text] [Related]
6. [Transdermal and oral hormone substitution with estrogens: a comparison].
Schindler AE
Zentralbl Gynakol; 1995; 117(10):504-7. PubMed ID: 7491831
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of estrogen replacement therapy.
Quigley JP; Williams D
Int J Fertil; 1986; 31(3 Suppl [ESTROGEN]):45-50. PubMed ID: 2906340
[No Abstract] [Full Text] [Related]
8. A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies. The Transdermal HRT Investigators Group.
Int J Fertil Menopausal Stud; 1993; 38(1):5-11. PubMed ID: 8485612
[TBL] [Abstract][Full Text] [Related]
9. [A new synthetic estrone derivative for the treatment of climacteric disorders].
Cyran W
Med Welt; 1979 Mar; 30(10):384-8. PubMed ID: 368495
[No Abstract] [Full Text] [Related]
10. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
[TBL] [Abstract][Full Text] [Related]
11. [Splenopeptides for climacteric complaints. Comparison of ovarian stimulation with transdermal estradiol substitution].
Lauritzen C; Teucher T; Schmitz H
Arzneimittelforschung; 1995 Mar; 45(3):315-22. PubMed ID: 7741793
[TBL] [Abstract][Full Text] [Related]
12. [The menopause. Therapeutic measures].
Rozenbaum H
Rev Fr Gynecol Obstet; 1985 Mar; 80(4):227-9. PubMed ID: 3992125
[TBL] [Abstract][Full Text] [Related]
13. [Clinical trial of a new synthetic estroprogestinic agent in the climacteric and menopause].
Moggian G; Tamburini E
Riv Ital Ginecol; 1970; 54(4):265-76. PubMed ID: 4949808
[No Abstract] [Full Text] [Related]
14. [Kinetics of a new patch for transdermal administration of 17 beta-estradiol].
Rohr UD; Nauert C; Ehrly AM
Zentralbl Gynakol; 1995; 117(10):531-9. PubMed ID: 7491836
[TBL] [Abstract][Full Text] [Related]
15. Intranasal estradiol: new formulation. Intranasal oestrogen delivery system: just a gimmick.
Prescrire Int; 2002 Dec; 11(62):163-5. PubMed ID: 12469692
[TBL] [Abstract][Full Text] [Related]
16. [The menopause. Therapeutic regimens].
Derrien J
Rev Fr Gynecol Obstet; 1985 Mar; 80(4):223-5. PubMed ID: 3992124
[TBL] [Abstract][Full Text] [Related]
17. [Use of a new steroid (Org OD 14) in the climacteric syndrome].
Cittadini J; Ben J; Badano AR; Denari HJ; Quiroga S; Marcus AE; Schlaen I; Figueroa Casas PR
Reproduccion; 1982; 6(2):69-79. PubMed ID: 6814971
[TBL] [Abstract][Full Text] [Related]
18. Effects on climacteric symptoms, bone and lipoprotein metabolism of hormone replacement therapy delivered by estradiol-releasing intravaginal rings: a pilot study.
Farish E; Barnes JF; Rankin M; Hart DM
Climacteric; 2003 Sep; 6(3):211-20. PubMed ID: 14567769
[TBL] [Abstract][Full Text] [Related]
19. [Bioavailability of 17 beta-estradiol after transdermal administration--dependence on the patch system].
Schmolling J; Kusche J; van der Ven H; Schander K
Zentralbl Gynakol; 1998; 120(3):121-5. PubMed ID: 9556902
[TBL] [Abstract][Full Text] [Related]
20. Cervical ripening with combinations of vaginal prostaglandin F2-alpha estradiol, and relaxin.
MacLennan AH; Green RC; Bryant-Greenwood GD; Greenwood FC; Seamark RF
Obstet Gynecol; 1981 Nov; 58(5):601-4. PubMed ID: 7029370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
